Eli Lilly

Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Fierce Pharma
Thu, 01/31/19 - 11:49 am
Allergan
Botox
Amgen
Eli Lilly
Teva Pharmaceuticals
migraines
Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial
Pharmaceutical Business Review
Wed, 01/30/19 - 10:05 am
Pfizer
Eli Lilly
tanezumab
clinical trials
osteoarthritis pain
osteoarthritis
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
Mon, 02/4/19 - 02:45 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
Reuters
Sat, 01/26/19 - 11:56 am
CVS Health
migraines
Amgen
Teva Pharmaceutical
Eli Lilly
Aimovig
Ajovy
Emgality
In another setback for Eli Lilly, FDA follows EMA in calling for a halt to new Lartruvo prescriptions
Endpoints
Fri, 01/25/19 - 12:12 pm
Eli Lilly
cancer
Lartruvo
FDA
EMA
A flashy 2019 start to pharma M&A, but will it last?
Biopharma Dive
Tue, 01/22/19 - 11:55 pm
M&A
Celgene
Bristol-Myers Squibb
Eli Lilly
Loxo Oncology
Lilly’s second immune-oncology candidate using Zymeworks’ Azymetric platform to start clinical trials
Pharmaceutical Business Review
Mon, 01/21/19 - 10:49 am
Eli Lilly
Zymeworks
drug development
Azymetric platform
On heels of Loxo buy, Lartruvo setback deals a blow to Lilly's oncology hopes
Fierce Pharma
Fri, 01/18/19 - 11:30 am
Eli Lilly
Lartruvo
soft tissue sarcoma
clinical trials
No bidding war for Loxo, so did Lilly overpay? Don’t rush to judgment, analysts say
Fierce Pharma
Fri, 01/18/19 - 10:27 am
Eli Lilly
Loxo Oncology
M&A
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Fierce Pharma
Fri, 01/18/19 - 12:09 am
Eli Lilly
NICE
Verzenio
breast cancer
Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days
Endpoints
Thu, 01/17/19 - 11:10 am
Eli Lilly
Loxo Oncology
M&A
JPMHC 2019
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Mon, 01/14/19 - 11:11 am
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
Sun, 01/13/19 - 11:32 am
NASH
Gilead Sciences
Merck
Roche
Novartis
Jecure Therapeutics
Pfizer
Celgene
Eli Lilly
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy
Yahoo/Reuters
Sat, 01/12/19 - 08:49 pm
Eli Lilly
Loxo Oncology
M&A
CAR-T
gene therapy
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
CNBC
Thu, 01/10/19 - 09:50 am
JNJ
Pfizer
Eli Lilly
Jamie Dimon
Amazon
JPMHC 2019
Does Eli Lilly's $8 Billion Splurge Make Array BioPharma a Buy Now?
Motley Fool
Wed, 01/9/19 - 09:43 am
Eli Lilly
Loxo Oncology
Array Biopharma
M&A
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
BioSpace
Wed, 01/9/19 - 09:40 am
JPMHC 2019
M&A
Eli Lilly
Loxo Oncology
SAGE Therapeutics
Sanofi
Regeneron
Bristol-Myers Squibb
Celgene
Novartis
Gilead Sciences
Don't fret about Lilly's 3rd-to-market start in CGRP, exec says. It's got big plans in migraine and pain, too
Fierce Pharma
Wed, 01/9/19 - 09:38 am
Eli Lilly
Emgality
migraines
CGRP blockers

Pages